ArticleCell communication and signaling : CCS2026
S100A4 promotes collective invasion of pancreatic ductal adenocarcinoma and its blockade suppresses metastasis.
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Most solid tumors invade peritumoral tissues as multicellular units while maintaining cell-cell interactions and epithelial characteristics, a process known as collective invasion. Our previous proteomic analysis revealed that S100-family proteins were upregulated in the PDAC secretome. Therefore, we aimed to elucidate the functional roles of these proteins in collective invasion and PDAC metastasis. To this end, we established a 3D collective invasion model using co-culture spheroids composed of PDAC cells and pancreatic stellate cells (PSCs). Using this model, we found that S100A4 contributes to collective invasion by mediating PDAC cell-PSC interactions, with S100A4 knockdown inhibiting collective invasion and S100A4 overexpression promoting it. Additionally, depletion of S100A in PDAC cells reduced trans-endothelial migration and cancer cell adhesion to endothelial cells. Mechanistically, PDAC cell-derived extracellular S100A4 promotes LAMB3 expression in PSCs. S100A4 depletion significantly reduced histological tumor aggressiveness in a pancreatic tumor orthotopic model and inhibited metastasis. To explore the therapeutic potential of these findings, we developed de novo S100A4-targeting inhibitory peptides using AI-guided structure modeling and confirmed their inhibitory effects on collective invasion. Collectively, our findings identify S100A4 as a critical driver of collective invasion and PDAC metastasis and support extracellular S100A4 as a potential target for AI-guided therapeutic intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.